Agreement with the non-profit organization The Systems Biology Institute to carry out research that aims to elucidate the mechanisms of action of NMN.

There is still plenty to learn about the biomolecular mechanisms of action of nicotinamide mononucleotide (NMN), and we consider this is a vital issue for aging research. With this in mind, and with the collaboration of the Systems Biology Institute (SBI), we have launched a series of life science research programs in order to clarify the mechanisms of action of NMN and its effects.

As the first step, we have concluded a research consignment (Elucidation of Intracellular Mechanism of NMN by Multi-Omics Analysis) with SBI to contribute to the science of NMN and aging research.

SBI’s CEO Dr Hiroaki Kitano has expressed his expectations regarding the research, "Through long-term administration, NMN is a substance expected to mitigate the physiological problems associated with aging. Although a number of physiological effects caused by the administration of NMN have been reported, the detailed biomolecular mechanisms have not yet been elucidated. This research will comprehensively analyze the effects of NMN at a cultured cell level and I hope it will be the first step leading to the next stage of research on the biomolecular and system biology of NMN."

About our research partner

The Systems Biology Institute (SBI)
CEO: Hiroaki Kitano
Address: Saisei Ikedayama Building, 5-10-25 Higashi-Gotanda, Shinagawa, Tokyo
http://www.sbi.jp/